Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.
Journal: Science advances
Published: July 04, 2025
Adjuvanted Protein Vaccines Boost RNA-Based Vaccines for Broader and More Potent Immune Responses.
Journal: Vaccines
Published: June 26, 2025
Synthetic RIG-I-Agonist RNA Induces Death of Hepatocellular Carcinoma Cells.
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: February 13, 2025
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
Journal: The Pediatric infectious disease journal
Published: January 08, 2025
The chosen few: Mycobacterium tuberculosis isolates for IMPAc-TB.
Journal: Frontiers in immunology
Published: May 03, 2024
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques.
Journal: npj antimicrobials and resistance
Published: May 02, 2024
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming.
Journal: Frontiers in immunology
Published: April 27, 2024
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Journal: Pediatrics
Published: December 13, 2023
Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor.
Journal: Microbiology (Reading, England)
Published: June 19, 2023
A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 20, 2023
Last Updated: 09/26/2026